NCT00811993 A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00808899 Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma Status TERMINATED Phase PHASE2
NCT00792363 Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations Status COMPLETED Phase PHASE2
NCT00786669 A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT00778102 A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2
NCT00766220 Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver Status WITHDRAWN Phase PHASE2
NCT00762255 A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT00755534 Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC Status TERMINATED Phase PHASE2
NCT00755118 Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc Status TERMINATED Phase PHASE2
NCT00730158 A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00718757 Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT00717990 Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment Status TERMINATED Phase PHASE2
NCT00708773 Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00695292 Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00689624 Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00682786 Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma Status COMPLETED Phase PHASE2
NCT00681876 Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00671801 Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I Status TERMINATED Phase PHASE1
NCT00671372 A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00642746 Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) Status TERMINATED Phase PHASE2